Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-09

FDA Approved: FESOTERODINE FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original application for fesoterodine fumarate (generic), enabling its marketing for overactive bladder treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

ORIG AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)